A Phase II Trial of Fetal Embolization for Vein of Galen Malformation
NCT: NCT07483255 · RECRUITING
Brief Summary
This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments will be performed every 6 months for 2 years (adjusted for gestational age). Data will be compared to historical cohorts.
Frequently Asked Questions
What is A Phase II Trial of Fetal Embolization for Vein of Galen Malformation?
A Phase II Trial of Fetal Embolization for Vein of Galen Malformation is a clinical trial registered under NCT07483255. Current status: RECRUITING.
What is the status of NCT07483255?
The current status of NCT07483255 (A Phase II Trial of Fetal Embolization for Vein of Galen Malformation) is: RECRUITING.
When did A Phase II Trial of Fetal Embolization for Vein of Galen Malformation start?
A Phase II Trial of Fetal Embolization for Vein of Galen Malformation started on 2026-07-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.